ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.320,96
0,33%
S&P 500
5.631,22
0,28%
US Dollar vs BRL
5,4483
0,00%
Bitcoin
64.095,75
-1,17%
Brent Oil
84,015
-0,39%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Tango Therapeutics Inc (TNGX)

  7. Tango Therapeutics Inc (TNGX) Notícias

TNGX

Tango Therapeutics (TNGX)

Tango Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TNGX
DataHoraFonteTítuloCódigoCompanhia
11/07/202217:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TNGXTango Therapeutics Inc
28/06/202217:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TNGXTango Therapeutics Inc
27/06/202208:00GlobeNewswire Inc.Tango Therapeutics Added to Russell 2000®, 3000® and Microcap® IndexesNASDAQ:TNGXTango Therapeutics Inc
10/06/202217:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TNGXTango Therapeutics Inc
10/06/202217:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TNGXTango Therapeutics Inc
08/06/202208:00GlobeNewswire Inc.Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare ConferenceNASDAQ:TNGXTango Therapeutics Inc
13/05/202201:09TipRanksSVB Securities Thinks Tango Therapeutics’ Stock is Going to RecoverNASDAQ:TNGXTango Therapeutics Inc
11/05/202208:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TNGXTango Therapeutics Inc
11/05/202208:00GlobeNewswire Inc.Tango Therapeutics Reports First Quarter 2022 Financial Results and Provides Business HighlightsNASDAQ:TNGXTango Therapeutics Inc
09/05/202208:00GlobeNewswire Inc.Tango Therapeutics to Participate in the Guggenheim Synthetic Lethality Day 2022NASDAQ:TNGXTango Therapeutics Inc
26/04/202209:11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TNGXTango Therapeutics Inc
26/04/202209:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TNGXTango Therapeutics Inc
29/03/202223:38TipRanksLeerink Partners Thinks Tango Therapeutics’ Stock is Going to RecoverNASDAQ:TNGXTango Therapeutics Inc
28/03/202217:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:TNGXTango Therapeutics Inc
28/03/202208:00GlobeNewswire Inc.Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business HighlightsNASDAQ:TNGXTango Therapeutics Inc
08/03/202218:57GlobeNewswire Inc.Tango Therapeutics Announces Presentation of Preclinical Data on TNG908, USP1 Inhibitor Program and Discovery Platform in Three Abstracts Accepted at AACR 2022 Annual MeetingNASDAQ:TNGXTango Therapeutics Inc
03/03/202211:41GlobeNewswire Inc.Tango Therapeutics Announces Presentation of TNG908 Preclinical Combination Data at 2022 ESMO Targeted Anticancer Therapies CongressNASDAQ:TNGXTango Therapeutics Inc
28/02/202209:00GlobeNewswire Inc.Tango Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:TNGXTango Therapeutics Inc
14/02/202218:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TNGXTango Therapeutics Inc
24/01/202209:51Dow Jones NewsTango Therapeutics Gets FDA OK for Cancer-Drug TrialNASDAQ:TNGXTango Therapeutics Inc
24/01/202209:00GlobeNewswire Inc.Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress UpdatesNASDAQ:TNGXTango Therapeutics Inc
04/01/202219:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TNGXTango Therapeutics Inc
11/11/202109:00GlobeNewswire Inc.Tango Therapeutics to Participate in the Jefferies London Healthcare ConferenceNASDAQ:TNGXTango Therapeutics Inc
09/11/202109:00GlobeNewswire Inc.Tango Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business HighlightsNASDAQ:TNGXTango Therapeutics Inc
01/11/202117:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TNGXTango Therapeutics Inc
01/11/202108:00GlobeNewswire Inc.Tango Therapeutics Announces Appointment of Dr. Marc Rudoltz as Chief Medical Officer and Doug Barry as General CounselNASDAQ:TNGXTango Therapeutics Inc
30/09/202117:31Business WireTango Therapeutics Announces Presentation of Preclinical Data on Lead Program and Discovery Platform in Five Abstracts Accepted at AACR-NCI-EORTC 2021NASDAQ:TNGXTango Therapeutics Inc
20/08/202117:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:TNGXTango Therapeutics Inc
17/08/202111:47Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:TNGXTango Therapeutics Inc
10/08/202110:00GlobeNewswire Inc.Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer TherapiesNASDAQ:TNGXTango Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TNGX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
TELB4
TELEBRAS PN
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
INBR32
Inter &
BOV
GFSA3
GAFISA ON
BOV
AZEV4
AZEVEDO PN
BOV
AMER3
Americanas ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados